| Product Information |
BR-1439_PI_01.pdf
|
| Registration Number |
BR-1439
|
| Generic Name |
Amivantamab
|
| Brand Name |
Rybrevant
|
| Dosage Strength |
350 mg/7 mL (50mg/mL)
|
| Dosage Form |
Concentrate For Solution For Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Type I glass vial with grey fluorotec-coated butyl rubber stopper and aluminum seal with white plastic flip-off cap (Box of 1's).
|
| Pharmacologic Category |
-
|
| Manufacturer |
Cilag AG
|
| Country of Origin |
Switzerland
|
| Trader |
N/A
|
| Importer |
Johnson & Johnson (Philippines), Inc.
|
| Distributor |
Johnson & Johnson (Philippines), Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
17 February 2023
|
| Expiry Date |
17 February 2028
|